GAPDH and diabetes mellitus: We provide evidence that a glycolytic metabolite downstream of phosphofructokinase and upstream of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is instrumental in mediating the effects of diabetes and chronic hyperglycaemia on β-cell metabolism.